Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Breast Cancer

Free Subscription Articles published in Ann Oncol Retrieve available abstracts of 106 articles: HTML format Text format

Single Articles

January 2012
1. PETIT JY , Lohsiriwat V, Rietjens M
   Reply to about locoregional recurrence risk after lipofilling in breast cancer patients.
   Ann Oncol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
2. SEMPRINI G , Cattin F, Lazzaro L, Cedolini C, et al
   About locoregional recurrence risk after lipofilling in breast cancer patients.
   Ann Oncol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
3. ANDRE F , Conforti R, Moeder CB, Mauguen A, et al
   Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancer.
   Ann Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. AUNE D , Chan DS, Greenwood DC, Vieira AR, et al
   Dietary fiber and breast cancer risk: a systematic review and meta-analysis of prospective studies.
   Ann Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. BUGGI F , Folli S, Curcio A, Casadei-Giunchi D, et al
   Multicentric/multifocal breast cancer with a single histotype: is the biological characterization of all individual foci justified?
   Ann Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
6. JENSEN JD , Knoop A, Laenkholm AV, Grauslund M, et al
   PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab.
   Ann Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. WOODS LM , Sasieni P, Rachet B
   Screening mammography and socioeconomic inequalities in breast cancer survival.
   Ann Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   November 2011
8. HE X , Esteva FJ, Ensor J, Hortobagyi GN, et al
   Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.
   Ann Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. MATHIEU MC , Mazouni C, Kesty NC, Zhang Y, et al
   Breast Cancer Index predicts pathological complete response and eligibility for breast conserving surgery in breast cancer patients treated with neoadjuvant chemotherapy.
   Ann Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. PEMMARAJU N , Munsell MF, Hortobagyi GN, Giordano SH, et al
    Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. COLLINS DM , O'Donovan N, McGowan PM, O'Sullivan F, et al
    Trastuzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) in HER-2-non-amplified breast cancer cell lines.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. PSYRRI A , Kalogeras KT, Kronenwett R, Wirtz RM, et al
    Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. ROMERO A , Martin M, Oliva B, de la Torre J, et al
    Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. JENKINS P , Scaife J, Freeman S
    Validation of a predictive model that identifies patients at high risk of developing febrile neutropaenia following chemotherapy for breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
15. DANESE MD , O'Malley C, Lindquist K, Gleeson M, et al
    An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. GORI S , Montemurro F, Spazzapan S, Metro G, et al
    Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. COLLEONI M , Rotmensz N, Maisonneuve P, Mastropasqua MG, et al
    Outcome of special types of luminal breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. HAEST K , Kumar A, Van Calster B, Leunen K, et al
    Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. ZAMAN K , Thurlimann B, Huober J, Schonenberger A, et al
    Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07).
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. SYED BM , Johnston SJ, Wong DW, Green AR, et al
    Long-term (37 years) clinical outcome of older women with early operable primary breast cancer managed in a dedicated clinic.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. LABONTE MJ , Wilson PM, Yang D, Zhang W, et al
    The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. AOGI K , Iwata H, Masuda N, Mukai H, et al
    A phase II study of eribulin in Japanese patients with heavily pretreated metastatic breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. EJLERTSEN B , Aldridge J, Nielsen KV, Regan MM, et al
    Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. GIORDANO A , Giuliano M, De Laurentiis M, Arpino G, et al
    Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. CORTES J , Calvo V, Ramirez-Merino N, O'Shaughnessy J, et al
    Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
26. VICI P , Brandi M, Giotta F, Foggi P, et al
    A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. PALLIS AG , Boukovinas I, Ardavanis A, Varthalitis I, et al
    A multicenter randomized phase III trial of vinorelbine/gemcitabine doublet versus capecitabine monotherapy in anthracycline- and taxane-pretreated women with metastatic breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. ROJO F , Garcia-Parra J, Zazo S, Tusquets I, et al
    Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. BOUVARD B , Hoppe E, Soulie P, Georgin-Mege M, et al
    High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapy.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. CLASSE JM , Baffert S, Sigal-Zafrani B, Fall M, et al
    Cost comparison of axillary sentinel lymph node detection and axillary lymphadenectomy in early breast cancer. A national study based on a prospective multi-institutional series of 985 patients 'on behalf of the Group of Surgeons from the French Unica
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. HOUSSAMI N , Costelloe CM
    Imaging bone metastases in breast cancer: evidence on comparative test accuracy.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. RIBEIRO JT , Macedo LT, Curigliano G, Fumagalli L, et al
    Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future?
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. BALMANA J , Diez O, Rubio IT, Cardoso F, et al
    BRCA in breast cancer: ESMO Clinical Practice Guidelines.
    Ann Oncol. 2011;22 Suppl 6:vi31-4.
    PubMed     Text format     Related articles   
    
    
    
    
34. CARDOSO F , Fallowfield L, Costa A, Castiglione M, et al
    Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Ann Oncol. 2011;22 Suppl 6:vi25-30.
    PubMed     Text format     Related articles   
    
    
    
    
35. AEBI S , Davidson T, Gruber G, Cardoso F, et al
    Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Ann Oncol. 2011;22 Suppl 6:vi12-24.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
36. SAINI KS , Taylor C, Ramirez AJ, Palmieri C, et al
    Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. MILLER KD , O'Neill A, Perez EA, Seidman AD, et al
    A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
38. SHIEH MP , Mehta RS
    Oligohydramnios associated with administration of weekly paclitaxel for triple-negative breast cancer during pregnancy.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
39. CLUZE C , Rey D, Huiart L, Bendiane MK, et al
    Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. DAWOOD S , Ueno NT, Valero V, Woodward WA, et al
    Identifying factors that impact survival among women with inflammatory breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. GLUCK S
    Does the addition of chemotherapy to adjuvant endocrine treatment add any benefit in ER-positive early breast cancer: can we rely on large randomized control trials in the era of personalized medicine?
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
42. ALLAWI Z , Cuzick J, Baum M
    Does trauma or an intercurrent surgical intervention lead to a short-term increase in breast cancer recurrence rates?
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. SERRANO MJ , Nadal R, Lorente JA, Salido M, et al
    Circulating cancer cells in division in an early breast cancer patient.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
44. GOLDHIRSCH A , Wood WC, Coates AS, Gelber RD, et al
    Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. LIEM X , Baranzelli MC, Penel N, Giard S, et al
    Is adjuvant chemotherapy useful in lobular breast cancer patients?
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
46. CESINARO AM , Maiorana A, Ficarra G, Pruneri G, et al
    Metaplastic carcinoma with extensive dendritic cell differentiation: a previously unrecognised type of triple-negative breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
47. CAMPONE M , Bondarenko I, Brincat S, Hotko Y, et al
    Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. LICHTMAN SM , Hurria A, Cirrincione CT, Seidman AD, et al
    Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. KITAGAWA K , Kawada K, Morita S, Inada M, et al
    Prospective evaluation of corrected QT intervals and arrhythmias after exposure to epirubicin, cyclophosphamide, and 5-fluorouracil in women with breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. ALBANELL J , Gonzalez A, Ruiz-Borrego M, Alba E, et al
    Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. PIERGA JY , Hajage D, Bachelot T, Delaloge S, et al
    High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. BUZDAR AU , Xu B, Digumarti R, Goedhals L, et al
    Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
53. PETIT JY , Botteri E, Lohsiriwat V, Rietjens M, et al
    Locoregional recurrence risk after lipofilling in breast cancer patients.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. RIIHIMAKI M , Thomsen H, Brandt A, Sundquist J, et al
    Death causes in breast cancer patients.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. LAMBERTINI M , Pronzato P, Giraudi S, Levaggi A, et al
    Letrozole withdrawal response in locally advanced breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
56. YOUNG AC , Mercer B, Perren TJ, Dodwell D, et al
    Anthracycline-induced cardiomyopathy in siblings with early breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
57. GALLO M , De Luca A, Lamura L, Normanno N, et al
    Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. FILIPOVIC A , Giamas G, Stebbing J
    The potential role of cyclooxygenase-2 (COX-2) during early breast cancer therapy.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
59. LEE MS , Lee EN, Ernst E
    Massage therapy for breast cancer patients: a systematic review.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
60. YERUSHALMI R , Tyldesley S, Kennecke H, Speers C, et al
    Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
61. 
    Abstracts of the IMPAKT 2011 Breast Cancer Conference. Brussels, Belgium. May 5-7, 2011.
    Ann Oncol. 2011;22 Suppl 2:ii19-73.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
62. OLSON EM , Lin NU, Dipiro PJ, Najita JS, et al
    Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
63. MONTAGNA E , Bagnardi V, Rotmensz N, Viale G, et al
    Breast cancer subtypes and outcome after local and regional relapse.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
64. REYAL F , Valet F, de Cremoux P, Mathiot C, et al
    Circulating tumor cell detection and transcriptomic profiles in early breast cancer patients.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
65. QIU L , Low HP, Chang CI, Strohsnitter WC, et al
    Novel measurements of mammary stem cells in human umbilical cord blood as prospective predictors of breast cancer susceptibility in later life.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
66. PULITI D , Miccinesi G, Manneschi G, Buzzoni C, et al
    Does an organised screening programme reduce the inequalities in breast cancer survival?
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
67. BALAKRISHNAN A , Haysom SA, Ravichandran D
    Adjuvant! Online does not significantly influence adjuvant chemotherapy decisions of a breast cancer multidisciplinary team (MDT): a prospective study.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
68. HEIL J , Buehler A, Golatta M, Rom J, et al
    Do patients with invasive lobular breast cancer benefit in terms of adequate change in surgical therapy from a supplementary preoperative breast MRI?
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. MASCI G , Gandini C, Zuradelli M, Pedrazzoli P, et al
    Fulvestrant for advanced male breast cancer patients: a case series.
    Ann Oncol. 2011;22:985.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
70. BIGANZOLI L , Di Vincenzo E, Jiang Z, Lichinitser M, et al
    First-line bevacizumab-containing therapy for breast cancer: results in patients aged >=70 years treated in the ATHENA study.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. ROMAN R , Sala M, Salas D, Ascunce N, et al
    Effect of protocol-related variables and women's characteristics on the cumulative false-positive risk in breast cancer screening.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. ROSATO V , Bosetti C, Talamini R, Levi F, et al
    Metabolic syndrome and the risk of breast cancer in postmenopausal women.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. HADJI P , Aapro MS, Body JJ, Bundred NJ, et al
    Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. MARTIN M , Sanchez-Rovira P, Munoz M, Baena-Canada JM, et al
    Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: efficacy and cardiac safety from the GEICAM/2004-05 study.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. KELLY CM , Pritchard KI, Trudeau M, Andreopoulou E, et al
    Coping with uncertainty: T1a,bN0M0 HER2-positive breast cancer, do we have a treatment threshold?
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. WU Y , Amonkar MM, Sherrill BH, O'Shaughnessy J, et al
    Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. FORNIER MN , Morris PG, Abbruzzi A, D'Andrea G, et al
    A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. CHAVEZ-MACGREGOR M , Zhao H, Kroll M, Fang S, et al
    Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. UNTCH M , Fasching PA, Konecny GE, von Koch F, et al
    PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel {+/-} darbepoetin alfa in prim
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. UNTCH M , von Minckwitz G, Konecny GE, Conrad U, et al
    PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin a
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. WEBERPALS JI , Tu D, Squire JA, Amin MS, et al
    Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. GEFFEN DB , Abu-Ghanem S, Sion-Vardy N, Braunstein R, et al
    The impact of the 21-gene recurrence score assay on decision making about adjuvant chemotherapy in early-stage estrogen-receptor-positive breast cancer in an oncology practice with a unified treatment policy.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
83. TRYFONOPOULOS D , Walsh S, Collins DM, Flanagan L, et al
    Src: a potential target for the treatment of triple-negative breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. CHUAH BY , Putti T, Salto-Tellez M, Charlton A, et al
    Serial changes in the expression of breast cancer-related proteins in response to neoadjuvant chemotherapy.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. CURIGLIANO G , Bagnardi V, Viale G, Fumagalli L, et al
    Should liver metastases of breast cancer be biopsied to improve treatment choice?
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. KNAPPSKOG S , Myklebust LM, Busch C, Aloysius T, et al
    RINF (CXXC5) is overexpressed in solid tumors and is an unfavorable prognostic factor in breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. KARLSSON P , Sun Z, Braun D, Price KN, et al
    Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. VALENTINI M , Milesi A, Bettini A, Tondini C, et al
    Type and trends in outcomes research in breast cancer between 2000 and 2007.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. MEERVELD-EGGINK A , de Weerdt O, van der Velden AM, Los M, et al
    Response to influenza virus vaccination during chemotherapy in patients with breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. AZIM HA JR , de Azambuja E, Colozza M, Bines J, et al
    Long-term toxic effects of adjuvant chemotherapy in breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. BATES M , Sperinde J, Kostler WJ, Ali SM, et al
    Identification of a subpopulation of metastatic breast cancer patients with very high HER2 expression levels and possible resistance to trastuzumab.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. CHARGARI C , Levy A, Vedrine L, Magne N, et al
    Current trials of cytotoxic and targeted agents in breast cancer: the caveat of radiotherapy.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
93. ANDERSON H , Hills M, Zabaglo L, A'hern R, et al
    Relationship between estrogen receptor, progesterone receptor, HER-2 and Ki67 expression and efficacy of aromatase inhibitors in advanced breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. HOZUMI Y , Suemasu K, Takei H, Aihara T, et al
    The effect of exemestane, anastrozole, and tamoxifen on lipid profiles in Japanese postmenopausal early breast cancer patients: final results of National Surgical Adjuvant Study BC 04, the TEAM Japan sub-study.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. JOENSUU H , Sperinde J, Leinonen M, Huang W, et al
    Very high quantitative tumor HER2 content and outcome in early breast cancer.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. ZURRIDA S , Montagna E, Naninato P, Colleoni M, et al
    Receptor status (ER, PgR and HER2) discordance between primary tumor and locoregional recurrence in breast cancer.
    Ann Oncol. 2011;22:479-80.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
97. AUTIER P , Boniol M, Middleton R, Dore JF, et al
    Advanced breast cancer incidence following population-based mammographic screening.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. ROUZIER R , Werkoff G, Uzan C, Mir O, et al
    Pregnancy-associated breast cancer is as chemosensitive as non-pregnancy-associated breast cancer in the neoadjuvant setting.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. PARK YH , Lee SJ, Cho EY, Choi YL, et al
    Clinical relevance of TNM staging system according to breast cancer subtypes.
    Ann Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. SMITH J , Axelrod D, Singh B, Kleinberg D, et al
     Prevention of breast cancer: the case for studying inhibition of IGF-1 actions.
     Ann Oncol. 2011;22 Suppl 1:i50-2.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. WARNER E
     Impact of MRI surveillance and breast cancer detection in young women with BRCA mutations.
     Ann Oncol. 2011;22 Suppl 1:i44-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. PARADISO A , Formenti S
     Hereditary breast cancer: clinical features and risk reduction strategies.
     Ann Oncol. 2011;22 Suppl 1:i31-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. MANGIA A , Malfettone A, Simone G, Darvishian F, et al
     Old and new concepts in histopathological characterization of familial breast cancer.
     Ann Oncol. 2011;22 Suppl 1:i24-30.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. 
     Hereditary breast and ovarian cancer: risks and challenges. Proceedings of a meeting. September 10-12, 2009. Bari, Italy.
     Ann Oncol. 2011;22 Suppl 1:i5-68.
     PubMed     Text format     Related articles   
     
     
     
     
105. MUGGIA F , Safra T, Dubeau L
     BRCA genes: lessons learned from experimental and clinical cancer.
     Ann Oncol. 2011;22 Suppl 1:i7-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. MUGGIA F , Smaldone V, Paradiso A
     Conclusions: fruits of the convergence of laboratory, clinic and public.
     Ann Oncol. 2011;22 Suppl 1:i67-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: